Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 324-327

  Moret, Myriam ^a,b,c,d,e   Pruneta Deloche, Valérie ^a,b,c,d,e   Sassolas, Agnès ^a,b,c,d,e   Marcais, Christophe ^a,b,c,d,e   Moulin, Philippe ^a,b,c,d,e  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSERM   (France)

^d CEMAGREF   (France)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

Autoimmunity; Hyperchylomicronemia; Lipoprotein lipase

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; LIPOPROTEIN LIPASE AUTOANTIBODY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SCREENING; CONTROLLED STUDY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 5; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; LETTER; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

AUTOANTIBODIES; AUTOIMMUNITY; BLOTTING, WESTERN; CHYLOMICRONS; HUMANS; HYDROLYSIS; HYPERLIPIDEMIAS; IMMUNOGLOBULIN G; LIGANDS; LIPOPROTEIN LIPASE; MODELS, BIOLOGICAL; TRIGLYCERIDES;

EID: 75049084867     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.07.039     Document Type: Letter

References (13)

1. Mead J.R., Irvine S.A., and Ramji D.P. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80 (2002) 753-769
2. Beigneux A.P., Davies B.S., Gin P., et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 5 (2007) 279-291
3. Mailly F., Palmen J., Muller D.P., et al. Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy. Hum Mutat 10 (1997) 465-473
4. Marcais C., Verges B., Charriere S., et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest 115 (2005) 2862-2869
5. Marcais C., Bernard S., Merlin M., et al. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency. Diabetologia 43 (2000) 1346-1352
6. Beaumont J.L. Gamma globulins and hyperlipemia. Hyperlipemia caused by autoantibodies. Ann Biol Clin (Paris) 27 (1969) 611-635
7. Okamoto Y., Tominaga K., Uemura S., Matsuoka H., Tsujii T., and Nakano H. Hypertriglyceridemia caused by the autoantibody to lipases for plasma lipoproteins: a case report. J Atheroscler Thromb 2 (1995) 66-69
8. Pruneta V., Moulin P., Labrousse F., Bondon P.J., Ponsin G., and Berthezene F. Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy. J Clin Endocrinol Metab 82 (1997) 791-796
9. Pruneta-Deloche V., Marcais C., Perrot L., et al. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia. J Clin Endocrinol Metab 90 (2005) 3995-3998
10. Kihara S., Matsuzawa Y., Kubo M., et al. Autoimmune hyperchylomicronemia. N Engl J Med 320 (1989) 1255-1259
11. de Carvalho J.F., Borba E.F., Viana V.S., Bueno C., Leon E.P., and Bonfa E. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?. Arthritis Rheum 50 (2004) 3610-3615
12. Kodera M., Hayakawa I., Komura K., et al. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. J Rheumatol 32 (2005) 629-636
13. Chappell D.A., Inoue I., Fry G.L., et al. Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J Biol Chem 269 (1994) 18001-18006